Published Studies
Published Clinical Studies
BEMER Physical Vascular Therapy has been the subject of peer-reviewed clinical research published in indexed medical journals. The three studies below represent the published literature from the foundational research period — independently reviewed, placebo-controlled where applicable, and available in full via the cited journals.
These studies form part of a broader clinical evidence base accumulated across 25 years of use in over 40 countries. The full body of research — spanning 15 medical specialties and more than 3,000 patients in observational and multi-centre settings — is summarised in the Research by Condition index.
Study 1 — Randomised Controlled Trial
MS-Related Fatigue
Piatkowski J, Kern S, Ziemssen T. Effect of BEMER Physical Vascular Therapy on Fatigue of Patients with Multiple Sclerosis: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial. Journal of Alternative and Complementary Medicine. 2009;15(5):507–511. DOI: 10.1089/acm.2008.0501
Study type
Monocenter, patient- and rater-blinded, placebo-controlled randomised trial
Ethics
International Ethical Committee, Freiburg (EC 02/TS/06); Declaration of Helsinki
Institution
Department of Neurology, University of Dresden
Population
41 enrolled, 37 with complete data (19 verum, 18 placebo) — RRMS with significant fatigue
Duration
12 weeks
Protocol
BEMER 3000 mat, 8 minutes twice daily at home; identical sham device for the placebo group; compliance monitored by diary
Both physical and cognitive dimensions of fatigue improved significantly; the psychological/psychosocial dimension showed no significant group difference. No adverse events were recorded.
“We were able to demonstrate a beneficial effect of BEMER intervention on MS fatigue.” — study authors
The only published RCT of BEMER for any neurological condition — conducted at a university neurology department, reaching statistical significance on both primary and secondary fatigue measures.
Study 2 — Randomised Controlled Trial
Subjective Tinnitus
Szilágyi I. BEMER Physical Vascular Therapy in the Treatment of Subjective Tinnitus. Otorhinologica Hungaria. 2010;56(4):251–260.
Study type
Randomised, double-blind, placebo-controlled clinical trial
Institution
ENT Department, Dr. Bugyi István Hospital, Szentes, Hungary
Population
214 patients — 108 BEMER, 106 placebo; idiopathic, noise-induced, and presbycusis-associated tinnitus
Period
July 2009 – June 2010
Protocol
8 consecutive days — 8 min whole-body mat + 20 min intensive applicator on the temporal region; both groups on standard pharmacotherapy (Pentoxifylline IV + Piracetam)
χ² test, p=0.001. BEMER combined with standard pharmacotherapy significantly outperformed pharmacotherapy alone for subjective tinnitus across all patient subgroups, with the best results in lower-severity tinnitus. No harmful side effects occurred in either group.
The largest BEMER RCT in the published literature — 214 patients, double-blind design, a statistically highly significant result across a well-characterised patient population.
Study 3 — Statutory Market Monitoring (Peer-Reviewed)
Quality of Life, Pain and Sleep
Bohn W, Hess L, Burger R. Results of a Market Monitoring Study of the BEMER Physical Vascular Therapy. Journal of Complementary and Integrative Medicine. 2013;10(Suppl):S5–S12. DOI: 10.1515/jcim-2013-0037
Study type
Statutory market monitoring of a CE-certified Class IIa medical device; peer-reviewed publication
Population
658 valid patient questionnaires across multiple diagnoses
Period
April 2011 – March 2013
Duration
6 weeks
Outcome measures
Jenkins Sleep Scale, NRS/VAS pain assessment, SF-12 Quality of Life questionnaire
Statistically significant improvements in sleep quality, pain, and quality of life — consistent across all underlying disease groups in the monitoring period.
A peer-reviewed publication based on statutory device monitoring — the regulatory evidence required for a CE-certified medical device — validating BEMER's effects across a broad mixed-diagnosis population using three established, validated outcome instruments simultaneously.
The Evidence Context
These three publications represent the indexed, peer-reviewed tier of BEMER's clinical evidence base. They sit within a much larger body of observational and multi-centre clinical data:
AFB Multi-Centre Study (1999–2002)
1,116 patients across 220 medical facilities in Germany, Austria, and Switzerland — the largest single observational dataset
Schönfeld General Practice Study (1999–2000)
201 patients, 87.6% positive outcomes across acute and chronic conditions
Klopp microcirculation research (2008)
Controlled studies demonstrating measurable microcirculatory improvements in diabetic polyneuropathy within 8–10 days
The full spectrum of conditions studied — with evidence levels, sample sizes, and outcome percentages — is indexed in the Research by Condition section.
Get Well Now is an independent BEMER SA agent and does not conduct or fund research. The studies referenced here reflect published, publicly available evidence. Always discuss BEMER therapy with your healthcare provider in the context of your specific health conditions.